Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5889 ARTÍCULOS , VIENDO DEL 2611 AL 2625

Disorders of metal metabolism

Ferreira CR, Gahl WA.

Transl Sci Rare Dis. 2017 Dec 18;2(3-4):101-139. doi: 10.3233/TRD-170015.

[The efficacy of botulinotherapy in the correction of the pain syndrome and quality of life of patients with cervical dystonia]

Karakulova YV, Loginova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(12):33-36. doi: 10.17116/jnevro201711712133-36.

Rehabilitation program based on sensorimotor recovery improves the static and dynamic balance and modifies the basal ganglia neurochemistry: A pilot 1H-MRS study on Parkinson's disease patients

Delli Pizzi S, Bellomo RG, Carmignano SM, Ancona E, Franciotti R, Supplizi M, Barassi G, Onofrj M, Bonanni L, Saggini R.

Medicine (Baltimore). 2017 Dec;96(50):e8732. doi: 10.1097/MD.0000000000008732.

Dystonic Seizures and Intense Hyperperfusion of the Basal Ganglia in a Patient with Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Matsumoto H, Hashida H, Takahashi Y.

Case Rep Neurol. 2017 Nov 23;9(3):272-276. doi: 10.1159/000484200. eCollection 2017 Sep-Dec.

Generalized dystonia : unusual mode of revelation of Moyamoya disease

Laatar F, Kacem I, Nasri A, Ben Djebara M, Gargouri A, Gouider R.

Tunis Med. 2017 Dec;95(12):504-505.

B/L Basal Ganglia Lesions in a Child Leading to a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency

Prabhakar N, Ahuja CK, Khandelwal N.

Ann Neurosci. 2018 Apr;25(1):50-52. doi: 10.1159/000481907. Epub 2017 Nov 21.

A therapeutic regimen for 3-hydroxyisobutyryl-CoA hydrolase deficiency with exercise-induced dystonia

Xu Y, Zhang J, Yu K, Feng F, Sun X, Li C, Li H, Cui L.

Eur J Paediatr Neurol. 2019 Sep;23(5):755-759. doi: 10.1016/j.ejpn.2017.11.004. Epub 2017 Nov 23.

SLC39A14 Deficiency

Tuschl K, Gregory A, Meyer E, Clayton PT, Hayflick SJ, Mills PB, Kurian MA.

2017 May 25 [updated 2022 Dec 8]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

PURA-Related Neurodevelopmental Disorders

Reijnders MRF, Leventer RJ, Lee BH, Baralle D, Selber P, Paciorkowski AR, St John M, Morgan AT, Anderson M, Hildebrand MS, Sanchez LD, Hunt D.

2017 Apr 27 [updated 2026 Mar 25]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2026.

Hyperkinetic Movement Disorder Emergencies

Cossu G, Colosimo C.

Curr Neurol Neurosci Rep. 2017 Jan;17(1):6. doi: 10.1007/s11910-017-0712-7.

Juvenile Huntington's Disease: Diagnostic and Treatment Considerations for the Psychiatrist

Quigley J.

Curr Psychiatry Rep. 2017 Feb;19(2):9. doi: 10.1007/s11920-017-0759-9.

Classification of involuntary movements in dogs: Paroxysmal dyskinesias

Lowrie M, Garosi L.

Vet J. 2017 Feb;220:65-71. doi: 10.1016/j.tvjl.2016.12.017. Epub 2017 Jan 3.

Poststroke Choreodystonia Responsive to Zopiclone: Further Evidence of a Role for the "Z-Drugs" in Hyperkinetic Movement Disorders

Bogdanova-Mihaylova P, Walsh RA.

Mov Disord Clin Pract. 2017 Feb 22;4(4):616-618. doi: 10.1002/mdc3.12471. eCollection 2017 Jul-Aug.

Wilson disease: neurologic features

Członkowska A, Litwin T, Chabik G.

Handb Clin Neurol. 2017;142:101-119. doi: 10.1016/B978-0-444-63625-6.00010-0.

Symptomatic treatment of neurologic symptoms in Wilson disease

Litwin T, Dušek P, Członkowska A.

Handb Clin Neurol. 2017;142:211-223. doi: 10.1016/B978-0-444-63625-6.00018-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias